BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35147042)

  • 41. Dedifferentiated liposarcoma with rhabdomyoblastic differentiation.
    Shimada S; Ishizawa T; Ishizawa K; Kamada K; Hirose T
    Virchows Arch; 2005 Nov; 447(5):835-41. PubMed ID: 16012847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
    Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
    Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunostaining for peroxisome proliferator gamma distinguishes dedifferentiated liposarcoma from other retroperitoneal sarcomas.
    Horvai AE; Schaefer JT; Nakakura EK; O'Donnell RJ
    Mod Pathol; 2008 May; 21(5):517-24. PubMed ID: 18204431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary dermal pleomorphic liposarcoma: utility of adipophilin and MDM2/CDK4 immunostainings.
    Ramírez-Bellver JL; López J; Macías E; Alegría-Landa V; Gimeno I; Pérez-Plaza A; Kutzner H; Requena L
    J Cutan Pathol; 2017 Mar; 44(3):283-288. PubMed ID: 27778364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers.
    Shimada S; Ishizawa T; Ishizawa K; Matsumura T; Hasegawa T; Hirose T
    Hum Pathol; 2006 Sep; 37(9):1123-9. PubMed ID: 16938516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paratesticular dedifferentiated liposarcoma with prominent myxoid stroma: report of a case and review of the literature.
    Tajima S; Koda K
    Med Mol Morphol; 2017 Jun; 50(2):112-116. PubMed ID: 25986682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting CDK4 (cyclin-dependent kinase) amplification in liposarcoma: A comprehensive review.
    Assi T; Kattan J; Rassy E; Nassereddine H; Farhat F; Honore C; Le Cesne A; Adam J; Mir O
    Crit Rev Oncol Hematol; 2020 Sep; 153():103029. PubMed ID: 32593094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Application of MDM2 Fluorescence In Situ Hybridization and Immunohistochemistry in Distinguishing Dedifferentiated Liposarcoma From Other High-grade Sarcomas.
    Song MJ; Cho KJ; Lee JS; Song JS
    Appl Immunohistochem Mol Morphol; 2017; 25(10):712-719. PubMed ID: 27028243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.
    Italiano A; Bianchini L; Gjernes E; Keslair F; Ranchere-Vince D; Dumollard JM; Haudebourg J; Leroux A; Mainguené C; Terrier P; Chibon F; Coindre JM; Pedeutour F
    Clin Cancer Res; 2009 Sep; 15(18):5696-703. PubMed ID: 19737942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A subset of fat-predominant angiomyolipomas label for MDM2: a potential diagnostic pitfall.
    Asch-Kendrick RJ; Shetty S; Goldblum JR; Sharma R; Epstein JI; Argani P; Cimino-Mathews A
    Hum Pathol; 2016 Nov; 57():7-12. PubMed ID: 27369456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dedifferentiated Liposarcoma of the Retroperitoneum With Heterologous Osteosarcomatous Differentiation and a Striking Aneurysmal Bone Cyst-Like Morphology.
    Van Haverbeke C; Van Dorpe J; Lecoutere E; Flucke U; Ferdinande L; Creytens D
    Int J Surg Pathol; 2017 Jun; 25(4):374-378. PubMed ID: 28193096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology.
    Kim YJ; Kim M; Park HK; Yu DB; Jung K; Song K; Choi YL
    Lab Invest; 2019 Sep; 99(9):1309-1320. PubMed ID: 31160689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dedifferentiated Liposarcoma Mimicking a Primary Colon Mass.
    Hollowoa B; Lamps LW; Mizell JS; English GW; Bridge JA; Ram R; Gardner JM
    Int J Surg Pathol; 2018 Apr; 26(2):174-179. PubMed ID: 28950740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Rare Case of Low-Grade Dedifferentiated Liposarcoma Presenting as a Pharyngeal Polyp: Avoiding a Pitfall With Significant Repercussions.
    Georgantzoglou N; Green D; Lefferts JA; Giannikaki L; Chliara E; Stavrianaki A; Kerr DA; Linos K
    Int J Surg Pathol; 2022 Jun; 30(4):405-412. PubMed ID: 34894818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MDM2+/CDK4+/p53+ oral liposarcoma: case report and review of the literature.
    Nikitakis NG; Lopes MA; Pazoki AE; Ord RA; Sauk JJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):194-201. PubMed ID: 11505267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipomas of the Oral Cavity: Utility of MDM2 and CDK4 in Avoiding Overdiagnosis as Atypical Lipomatous Tumor.
    Stojanov IJ; Mariño-Enriquez A; Bahri N; Jo VY; Woo SB
    Head Neck Pathol; 2019 Jun; 13(2):169-176. PubMed ID: 29748845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterologous Liposarcomatous Differentiation in Malignant Phyllodes Tumor is Histologically Similar but Immunohistochemically and Molecularly Distinct from Well-differentiated Liposarcoma of Soft Tissue.
    Inyang A; Thomas DG; Jorns J
    Breast J; 2016 May; 22(3):282-6. PubMed ID: 26843318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A challenging diagnosis of mesenchymal neoplasm of the colon: colonic dedifferentiated liposarcoma with lymph node metastases-a case report and review of the literature.
    Guadagno E; Peltrini R; Stasio L; Fiorentino F; Bucci L; Terracciano L; Insabato L
    Int J Colorectal Dis; 2019 Oct; 34(10):1809-1814. PubMed ID: 31501928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chromosome-12 copy number alterations and MDM2, CDK4 and TP53 expression in soft tissue liposarcoma.
    Segura-Sánchez J; González-Cámpora R; Pareja-Megia MJ; García-Escudero A; Galera-Ruiz H; López-Beltrán A
    Anticancer Res; 2006; 26(6C):4937-42. PubMed ID: 17214366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High amplification levels of MDM2 and CDK4 correlate with poor outcome in patients with dedifferentiated liposarcoma: A cytogenomic microarray analysis of 47 cases.
    Ricciotti RW; Baraff AJ; Jour G; Kyriss M; Wu Y; Liu Y; Li SC; Hoch B; Liu YJ
    Cancer Genet; 2017 Dec; 218-219():69-80. PubMed ID: 29153098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.